Matsui Takashi, Kojitani Eiji, Takasawa Taichi, Suto Arisa, Tamari Ami, Watanabe Go, Kodera Yoshio
Department of Physics, School of Science, Kitasato University, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0373, Japan; Center for Disease Proteomics, School of Science, Kitasato University, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0373, Japan.
Department of Physics, School of Science, Kitasato University, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0373, Japan.
Biochem Biophys Res Commun. 2023 Jan 15;640:97-104. doi: 10.1016/j.bbrc.2022.11.094. Epub 2022 Dec 2.
Structural proteomics techniques are useful for identifying the binding sites of proteins. The surface of a target protein with and without a bound binding partner is artificially labeled using a hydroxy radical, deuterium, or a low-molecular-weight chemical, and the difference in the label strength with and without the bound partner is determined. Label strength maps are then prepared on the Protein Data Bank (PDB) structure to identify the binding surface. However, the surface-accessible sites determined using such structural proteomics methods are frequently inconsistent with those calculated based on PDB structures, speculating that the measurement determines chemical accessibility rather than solvent accessibility. In this study, the solvent-accessible surface of human serum albumin was analyzed using covalent protein labeling with varying concentrations of CHO and then compared to surfaces derived from 27 PDB structures. The results indicated that inconsistencies in solvent-accessible surface area values calculated from PDB structures are not caused by the limited capabilities of liquid chromatography-mass spectrometry coupled with covalent protein painting but instead are due to the lack of PDB data representing the structures in solution.
结构蛋白质组学技术对于识别蛋白质的结合位点很有用。使用羟基自由基、氘或低分子量化学物质对有和没有结合伴侣的靶蛋白表面进行人工标记,并确定有和没有结合伴侣时标记强度的差异。然后在蛋白质数据库(PDB)结构上制备标记强度图以识别结合表面。然而,使用这种结构蛋白质组学方法确定的表面可及位点常常与基于PDB结构计算的位点不一致,推测这种测量确定的是化学可及性而非溶剂可及性。在本研究中,使用不同浓度的CHO进行共价蛋白质标记分析了人血清白蛋白的溶剂可及表面,然后与来自27个PDB结构的表面进行比较。结果表明,从PDB结构计算出的溶剂可及表面积值的不一致不是由液相色谱 - 质谱联用共价蛋白质标记的能力限制引起的,而是由于缺乏代表溶液中结构的PDB数据。